Inventor · disambiguated record
Michaela Serpi
Also filed as: SERPI MICHAELA
8 granted patents·4 pending applications·15 citations·filing 2011–2024
81Inventor score
Top patents by PatentIndex Score
12 records- 0188US11352387B22′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compoundsNuCana plc·Filed 2020·Granted Jun 7, 2022·2 cites·19 claims
- 0288US10570168B22′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compoundsNuCana plc·Filed 2015·Granted Feb 25, 2020·5 cites·4 claims
- 0382US10906929B2Phosphoramidate nucleoside derivatives as anticancer agentsNuCana plc·Filed 2017·Granted Feb 2, 2021·2 cites·16 claims
- 0480US10662213B2Gemcitabine prodrugsNuCana plc·Filed 2015·Granted May 26, 2020·3 cites·13 claims
- 0576US8940313B2Tyrosine-based prodrugs of antiviral agentsMCKENNA CHARLES E·Filed 2011·Granted Jan 27, 2015·3 cites·17 claims
- 0675US12054510B22′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compoundsNuCana plc·Filed 2022·Granted Aug 6, 2024·0 cites·8 claims
- 0763US2025163096A12' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compoundsNuCana plc·Filed 2024·Application pending·0 cites
- 0863US2021130387A1Phosphoramidate nucleoside derivatives as anticancer agentsNuCana plc·Filed 2021·Application pending·0 cites
- 0962US11629164B2Gemcitabine prodrugsNuCana plc·Filed 2020·Granted Apr 18, 2023·0 cites·10 claims
- 1055US2022024963A1Salt of triphosphate phosphoramidates of nucleotides as anticancer compoundsNuCana plc·Filed 2021·Application pending·0 cites
- 1151US11560400B2Salts of diphosphate phosphoramidate of nucleosides as anticancer compoundsNuCana plc·Filed 2018·Granted Jan 24, 2023·0 cites·27 claims
- 1240US2019375778A1Adenosine derivatives for use in the treatment of cancerNuCana plc·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michaela Serpi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →